DLB

Dolby Laboratories, Inc. [DLB] Stock Forecast

Q: What is Dolby Laboratories, Inc. stock symbol ?

Dolby Laboratories, Inc. is a US stock, located in San francisco of Ca and trading under the symbol DLB

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

DLB Stock Summary

Earnings are expected to fall -100% next year

Unstable dividend track record

EPS has been decreasing for the past 3 quarters (Quarter statements)

Profit margins (0.15%) are lower than the previous year (0.19%)

DLB has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top 10 Correlated ETFs

DLB

Top 10 Correlated Stocks

DLB

In the News

DLB Financial details

Company Rating

Neutral

Market Cap

7.66B

Income

200.66M

Revenue

1.3B

Book val./share

24.61

Cash/share

9.24

Dividend

1.11

Dividend %

1.31%

Employees

2.25K

Optionable

Shortable

Yes

Earnings

02 May 2024

P/E

40.4

Forward P/E

PEG

28.59

P/S

6.2

P/B

3.44

P/C

8.48

P/FCF

23.94

Quick Ratio

3.15

Current Ratio

3.52

Debt / Equity

0.02

LT Debt / Equity

0.02

EPS (TTM)

2.1

EPS next Y

EPS next Q

EPS this Y

8.7%

EPS next Y

EPS next 5Y

EPS last 5Y

-4.44%

Revenue last 5Y

-4.06%

Revenue Q/Q

-2.62%

EPS Q/Q

-41.18%

SMA20

-4.76%

SMA50

-2.44%

SMA100

-6.98%

Inst Own

54.09%

Inst Trans

0.96%

ROA

ROE

ROC

0.07%

Gross Margin

88%

Oper. Margin

15%

Profit Margin

15%

Payout

52%

Shs Outstand

Shs Float

Target Price

52W Range

75.87-91.02

52W High

-13.89%

52W Low

+4.48%

RSI

Rel Volume

0.08

Avg Volume

372.44K

Volume

28.92K

Perf Week

-3.69%

Perf Month

-4.83%

Perf Quarter

-1.1%

Perf Half Y

-3.91%

Beta

0.97

Volatility

1.23%, 2%

Prev Close

0.49%

Price

78.36

Change

-0.8%

DLB Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-29

Metric	2019-09-27	2020-09-25	2021-09-24	2022-09-30	2023-09-29
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	12.22	11.55	12.66	12.54	10.53
Net income per share	2.51	2.3	3.07	1.84	2
Operating cash flow per share	3.22	3.42	4.42	3.19	2.94
Free cash flow per share	2.11	2.73	3.89	2.59	2.71
Cash per share	9.02	11.13	12.49	8.09	9.23
Book value per share	22.7	24.19	25.67	22.46	24.59
Tangible book value per share	15.91	17.87	21.15	17.74	18.75
Share holders equity per share	22.7	24.19	25.67	22.46	24.59
Interest debt per share	0	0.81	0.72	0.51	0.53
Market cap	6.48B	6.54B	9.36B	6.51B	7.59B
Enterprise value	5.69B	5.54B	8.2B	5.95B	6.9B
P/E ratio	25.41	28.25	30.16	35.39	39.65
Price to sales ratio	5.22	5.63	7.3	5.2	7.52
POCF ratio	19.78	19.01	20.9	20.45	26.92
PFCF ratio	30.27	23.78	23.79	25.14	29.21
P/B Ratio	2.81	2.69	3.6	2.9	3.22
PTB ratio	2.81	2.69	3.6	2.9	3.22
EV to sales	4.58	4.77	6.4	4.74	6.84
Enterprise value over EBITDA	14.07	16.67	17.68	18.02	31.46
EV to operating cash flow	17.35	16.13	18.32	18.66	24.45
EV to free cash flow	26.55	20.17	20.86	22.94	26.54
Earnings yield	0.04	0.04	0.03	0.03	0.03
Free cash flow yield	0.03	0.04	0.04	0.04	0.03
Debt to equity	0	0.03	0.03	0.02	0.02
Debt to assets	0	0.03	0.02	0.02	0.02
Net debt to EBITDA	-1.97	-2.98	-2.48	-1.73	-3.17
Current ratio	4.5	5.79	5.58	4.72	3.52
Interest coverage	1.51K	1.18K	718.98	524.38	-1.36K
Income quality	1.28	1.48	1.41	1.73	1.47
Dividend Yield	0.01	0.01	0.01	0.02	0.01
Payout ratio	0.3	0.38	0.29	0.54	0.41
Sales general and administrative to revenue	0.17	0.19	0.17	0.22	0.19
Research and developement to revenue	0.19	0.21	0.2	0.21	0.2
Intangibles to total assets	0.18	0.17	0.15	0.18	0.19
Capex to operating cash flow	-0.35	-0.2	-0.12	-0.19	-0.08
Capex to revenue	-0.09	-0.06	-0.04	-0.05	-0.02
Capex to depreciation	-1.33	-0.76	-0.48	-0.57	-0.31
Stock based compensation to revenue	0.06	0.07	0.08	0.09	0.09
Graham number	35.81	35.39	42.08	30.5	33.25
ROIC	0.1	0.08	0.11	0.08	0.11
Return on tangible assets	0.11	0.1	0.12	0.08	0.08
Graham Net	7.01	9.04	10.67	6.97	6.56
Working capital	1.07B	1.28B	1.44B	1.03B	1.07B
Tangible asset value	1.8B	1.95B	2.14B	1.77B	1.8B
Net current asset value	872.82M	1.07B	1.26B	872.37M	880.22M
Invested capital	0	0.03	0.03	0.02	0.02
Average receivables	260.96M	363.23M	378.31M	417.31M	432.03M
Average payables	18.57M	13.91M	15.2M	15.98M	17.55M
Average inventory	29.27M	28.94M	18.26M	17.26M	29.59M
Days sales outstanding	113.11	107.35	118.2	122.18	160.72
Days payables outstanding	34.52	31.44	49.91	36.59	65.27
Days of inventory on hand	73.36	63.66	30.78	60.8	111.12
Receivables turnover	3.23	3.4	3.09	2.99	2.27
Payables turnover	10.57	11.61	7.31	9.98	5.59
Inventory turnover	4.98	5.73	11.86	6	3.28
ROE	0.11	0.1	0.12	0.08	0.08
Capex per share	-1.12	-0.69	-0.54	-0.59	-0.23

Quarterly Fundamentals Overview

Last date of statement is 2023-09-29 for Q4

Metric	2022-09-30	2022-12-30	2023-03-31	2023-06-30	2023-09-29
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.87	3.49	3.92	3.12	3.04
Net income per share	0.29	0.83	1	0.17	0.1
Operating cash flow per share	0.53	0.59	1.09	1.27	0.89
Free cash flow per share	0.42	0.51	1.01	1.19	0.8
Cash per share	8.34	7.91	8.5	9.3	9.24
Book value per share	23.14	23.85	24.53	24.74	24.61
Tangible book value per share	18.27	18.95	19.69	18.6	18.77
Share holders equity per share	23.14	23.85	24.53	24.74	24.61
Interest debt per share	0.53	0.5	0.85	0.52	0.53
Market cap	6.32B	6.77B	8.18B	8B	7.59B
Enterprise value	5.76B	6.19B	7.54B	7.29B	6.89B
P/E ratio	56.97	21.31	21.38	122.03	206.44
Price to sales ratio	22.73	20.2	21.77	26.83	26.11
POCF ratio	123.26	119.96	78.29	66.08	89.22
PFCF ratio	155.78	137.56	84.37	70.39	98.73
P/B Ratio	2.82	2.96	3.48	3.38	3.22
PTB ratio	2.82	2.96	3.48	3.38	3.22
EV to sales	20.69	18.47	20.07	24.43	23.71
Enterprise value over EBITDA	161.25	50.63	69.03	112.41	84.08
EV to operating cash flow	112.17	109.7	72.17	60.18	81.05
EV to free cash flow	141.76	125.8	77.76	64.1	89.69
Earnings yield	0	0.01	0.01	0	0
Free cash flow yield	0.01	0.01	0.01	0.01	0.01
Debt to equity	0.02	0.02	0.02	0.02	0.02
Debt to assets	0.02	0.02	0.02	0.02	0.02
Net debt to EBITDA	-15.95	-4.74	-5.86	-11.03	-8.48
Current ratio	4.72	4.65	4.66	3.47	3.52
Interest coverage	94.42	1.16K	2.49	139.78	0
Income quality	1.85	0.71	1.09	7.38	8.58
Dividend Yield	0	0	0	0	0
Payout ratio	0.87	0.33	0.27	1.58	2.81
Sales general and administrative to revenue	0.21	0.18	0.16	0.23	0.23
Research and developement to revenue	0.22	0.19	0.18	0.23	0.24
Intangibles to total assets	0.18	0.17	0.17	0.2	0.19
Capex to operating cash flow	-0.21	-0.13	-0.07	-0.06	-0.1
Capex to revenue	-0.04	-0.02	-0.02	-0.02	-0.03
Capex to depreciation	-0.47	-0.32	-0.31	-0.31	-0.34
Stock based compensation to revenue	0.1	0.09	0.08	0.1	0.1
Graham number	12.2	21.08	23.48	9.77	7.29
ROIC	0.01	0.03	0.03	0	0
Return on tangible assets	0.01	0.03	0.04	0.01	0
Graham Net	7.18	7.25	8.02	6.53	6.56
Working capital	1.03B	1.06B	1.15B	1.05B	1.07B
Tangible asset value	1.77B	1.82B	1.89B	1.78B	1.8B
Net current asset value	872.37M	893.42M	982.46M	844.15M	880.22M
Invested capital	0.02	0.02	0.02	0.02	0.02
Average receivables	413.16M	462.6M	532.05M	509.01M	451.91M
Average payables	15.5M	15.77M	17.27M	16.28M	18.16M
Average inventory	23.82M	24.83M	28.23M	31.38M	34.01M
Days sales outstanding	135.77	135.84	133.74	138.59	137.64
Days payables outstanding	34.3	45.36	37.65	33.37	52.97
Days of inventory on hand	57.01	68.21	66.55	70.24	90.18
Receivables turnover	0.66	0.66	0.67	0.65	0.65
Payables turnover	2.62	1.98	2.39	2.7	1.7
Inventory turnover	1.58	1.32	1.35	1.28	1
ROE	0.01	0.03	0.04	0.01	0
Capex per share	-0.11	-0.08	-0.08	-0.08	-0.09

DLB Dividend History

DLB Frequently Asked Questions

What is Dolby Laboratories, Inc. stock symbol ?

Dolby Laboratories, Inc. is a US stock , located in San francisco of Ca and trading under the symbol DLB

What is Dolby Laboratories, Inc. stock quote today ?

Dolby Laboratories, Inc. stock price is $78.36 today.

Is Dolby Laboratories, Inc. stock public?

Yes, Dolby Laboratories, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 372.44K
Market Capitalization 7.66B
Employee 2.25K
CEO Mr. Kevin J. Yeaman
Headquarters San Francisco,CA,US
IPO Date 2005-02-17
Website https://www.dolby.com

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.